Journal of the American Academy of Child & Adolescent Psychiatry
New researchSuicide Attempts and Nonsuicidal Self-Injury in the Treatment of Resistant Depression in Adolescents: Findings from the TORDIA Study
Section snippets
Method
Detailed descriptions of participants, assessments, treatments and outcomes are available elsewhere.14, 16, 17 Therefore, we focus here on participant characteristics, measures, and procedures relevant to the outcomes of SAs and NSSI. The study was reviewed by each site's local institutional review board. All subjects gave informed assent/consent (as appropriate), and parents gave informed consent.
Baseline Presentation
Table 1 provides descriptive data on the baseline characteristics of the total sample and for subgroups of youths presenting at baseline with histories of no SIB, NSSI only, SAs only, and NSSI+SAs. Histories of NSSI were somewhat more common than SA histories at baseline: 78 youths (23.9%) reported a history of NSSI only, 31 (9.5%) reported a history of SAs only, and a sizeable subgroup (46 youths, 14%) reported histories of NSSI+SAs. The high likelihood of combined NSSI and suicide attempts
Discussion
The present results underscore both the prevalence and significance of NSSI among adolescents with chronic treatment-resistant depression. Consistent with results indicating relatively high rates of NSSI in the general adolescent population,2, 8 NSSI histories were relatively common in the TORDIA sample (38%) and more common than SA histories (23%). In addition, NSSI and suicide attempts tended to co-occur, with 14% of the sample presenting with baseline histories of both NSSI and SAs, and
References (36)
- et al.
Non-suicidal self-injury among adolescents: diagnostic correlates and relation to suicide attempts
Psychiatry Res
(2006) - et al.
Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior
J Am Acad Child Adolesc Psychiatry
(2001) - et al.
Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version (K-SADS-PL): initial reliability and validity data
J Am Acad Child Adolesc Psychiatry
(1997) - et al.
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response
J Am Acad Child Adolesc Psychiatry
(2009) - et al.
Norms and sensitivity of the adolescent version of the drug use screening inventory
Addict Behav
(1995) - et al.
Youth risk behavior surveillance—United States, 2009
MMWR Surveill Summ
(2009) - et al.
Prevalence and psychological correlates of occasional and repetitive deliberate self-harm in adolescents
Arch Pediatr Adolesc Med
(2007) - et al.
Distinguishing between subgroups of adolescents who self-harm
Suicide Life Threat Behav
(2009) - Taylor HL, McGrath EP, Thrasher D, Hickel D, Asarnow JR. A Community Partnership Model for Youth Suicide Prevention....
- et al.
The epidemiology and phenomenology of non-suicidal self-injurious behavior among adolescents: a critical review of the literature
Arch Suicide Res
(2007)
An exploratory study of correlates, onset, and offset of non-suicidal self-injury
Arch Suicide Res
Longitudinal prediction of adolescent nonsuicidal self-injury: examination of a cognitive vulnerability-stress model
J Clin Child Adolesc Psychol
Prevalence and clinical correlates of deliberate self-harm among a community sample of Italian adolescents
J Adolesc.
Risk for suicide attempts among adolescents who engage in non-suicidal self-injury
Arch Suicide Res
Deliberate self-harm in young people: characteristics and subsequent mortality in a 20-year cohort of patients presenting to hospital
J Clin Psychiatry
Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder
Arch Gen Psychiatry
Emotional dysregulation and interpersonal difficulties as risk factors for nonsuicidal self-injury in adolescent girls
J Abnorm Child Psychol
Predictors of spontaneous and systematically assessed suicidal adverse events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study
Am J Psychiatry
Cited by (419)
Can clinical and subclinical forms of narcissism be considered risk factors for suicide-related outcomes? A systematic review
2024, Journal of Psychiatric ResearchEditorial: Bringing Parenting Into Focus: A Decade of Longitudinal Follow-Up Reveals Potential Parenting Targets for Early Intervention for Adolescent Self-Injury
2024, Journal of the American Academy of Child and Adolescent PsychiatryRisk Factors of Depression Screened by Two-Sample Mendelian Randomization Analysis: A Systematic Review
2024, Biomedical and Environmental SciencesA preliminary investigation into cortical structural alterations in adolescents with nonsuicidal self-injury
2023, Psychiatry Research - NeuroimagingPrefrontal oxygenation varies as a function of response inhibition performance in healthy participants but not in youth with non-suicidal self-injury
2023, Psychiatry Research - Neuroimaging
Funded by National Institute of Mental Health grants MH61835 (Pittsburgh); MH61856 (Galveston); MH61864 (UCLA); MH61869 (Portland); MH61958 (Dallas); and MH62014 (Brown), and the Advanced Center for Early-Onset Mood and Anxiety Disorders (MH66371, D.A.B.).
The authors thank the youth, families, staff, and colleagues who made this project possible. The opinions and assertions contained in this report are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of Health and Human Services, the National Institutes of Health, or the National Institute of Mental Health.
Disclosure: Dr. Asarnow has received research grants from the National Institute of Mental Health. She has received honoraria from the California Institute of Mental Health, Hathaways-Sycamores, and the Melissa Institute. Dr. Emslie receives research support from the National Institute of Mental Health, Biobehavioral Diagnostics Inc., Eli Lilly and Co., Forest, GlaxoSmithKline, and Somerset. He has served as a consultant for Biobehavioral Diagnostics Inc., Eli Lilly and Co., Forest, GlaxoSmithKline, Pfizer, and Wyeth. He has served on the speakers' bureau for Forest. Dr. Wagner has received honoraria from Physicians Postgraduate Press, the National Institutes of Health, CMP Medica, UBM Medica, Krog and Partners, American Institute of Biological Sciences, Mexican Psychiatric Association, American Academy of Child and Adolescent Psychiatry, American Psychiatric Association, Madison Institute of Medicine, Wolters Kluwer Health, Contemporary Forums, Quantia Communications, Doctors Hospital at Renaissance, CME LLC, Springer Publishing. He serves as a deputy editor of the Journal of Clinical Psychiatry. Dr. Keller has served as a consultant to Medtronic, Sierra Neuropharmaceuticals, and CENEREX (without renumeration). He has received grant support from Pfizer. Dr. Birmaher has served as a consultant for Schering Plough. He has received research support from the National Institute of Mental Health. He has participated in forums sponsored by Dey Pharma, L.P.: Major Depressive Disorder Regional Advisory Board Meeting. He has received royalties for publications from Random House, and Lippincott Williams and Wilkins. Dr. McCracken has received research support from Eli Lilly and Co., McNeil, Bristol-Myers Squibb, and Shire; and has served as a consultant for Shire, Eli Lilly and Co., McNeil, Pfizer, Janssen, Johnson and Johnson, Novartis, and Wyeth. Dr. Brent has received research support from the National Institutes of Mental Health. He has received royalties from Guilford Press. He serves as an editor of UpToDate Psychiatry. Drs. Spirito, Berk, Clarke, and Vitiello, and Ms. Mayes and Ms. Porta, report no biomedical financial interests or potential conflicts of interest.
This article is discussed in an editorial by Dr. Paul Wilkinson on page 741.